Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

1.3K
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.3K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

1.0K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

1.2K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.2K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

1.1K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.1K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

4.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.0K
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

1.0K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[END-STAGE RENAL DISEASE, DIALYSIS TREATMENT AND MANAGEMENT OF COMORBIDITY].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti·2017
Same author

[DIET CHARACTERISTICS IN PATIENTS WITH CHRONIC KIDNEY DISEASE].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti·2017
Same author

[DIAGNOSTIC APPROACH TO PATIENTS WITH CHRONIC KIDNEY DISEASE].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti·2017
Same author

[GASTROESOPHAGEAL REFLUX DISEASE – A MULTIFACETED DISEASE].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti·2017
Same author

[ESOPHAGEAL TUMORS IN FAMILY PHYSICIAN PRACT].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti·2017
Same author

[What General/Family Medicine Practitioner should Know about Viral Hepatitis].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti·2017
Same journal

[CHARACTERISTIC FEATURES OF PRESSURE ULCER INFECTION].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti·2017
Same journal

[PERSONALIZED APPROACH TO PATIENT WITH CHRONIC WOUND IN FAMILY MEDICINE].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti·2017
Same journal

[APPLICATION OF TOPICAL HEMOGLOBIN SPRAY IN INFECTED POSTTRAUMATIC AND POSTOPERATIVE WOUNDS].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti·2017
Same journal

[APPLICATION OF NEGATIVE PRESSURE THERAPY].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti·2017
Same journal

[PATIENTS WITH PRESSURE ULCERS IN THE UNIFIED EMERGENCY ADMISSION DEPARTMENT – OUR REALITY].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti·2017
Same journal

[Proposition of algorhythm for treatment with hyperbaric oxygenation Hyperbaric oxygenation in Rijeka Clinical Hospital Center].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti·2017
See all related articles

Related Experiment Video

Updated: Feb 19, 2026

Normothermic Cardiac Arrest and Cardiopulmonary Resuscitation: A Mouse Model of Ischemia-Reperfusion Injury
10:25

Normothermic Cardiac Arrest and Cardiopulmonary Resuscitation: A Mouse Model of Ischemia-Reperfusion Injury

Published on: August 30, 2011

18.8K

[PATHOPHYSIOLOGY OF THE CARDIORENAL SYNDROME].

I Balint, J Vučak, N Bašić-Marković

    Acta Medica Croatica : Casopis Hravatske Akademije Medicinskih Znanosti
    |November 1, 2017
    PubMed
    Summary
    This summary is machine-generated.

    Cardiorenal syndrome involves heart and kidney damage, with five types based on primary organ dysfunction. Early diagnosis and treatment are crucial for managing this complex condition.

    More Related Videos

    A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
    07:52

    A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

    Published on: November 7, 2017

    22.2K
    Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
    08:35

    Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

    Published on: May 26, 2022

    4.2K

    Related Experiment Videos

    Last Updated: Feb 19, 2026

    Normothermic Cardiac Arrest and Cardiopulmonary Resuscitation: A Mouse Model of Ischemia-Reperfusion Injury
    10:25

    Normothermic Cardiac Arrest and Cardiopulmonary Resuscitation: A Mouse Model of Ischemia-Reperfusion Injury

    Published on: August 30, 2011

    18.8K
    A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
    07:52

    A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

    Published on: November 7, 2017

    22.2K
    Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
    08:35

    Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

    Published on: May 26, 2022

    4.2K

    Area of Science:

    • Cardiology
    • Nephrology
    • Pathophysiology

    Background:

    • Cardiorenal syndrome is a complex disorder where heart or kidney damage impacts the other organ.
    • Five types exist, classified by the primary organ affected and disease chronicity.
    • Pathophysiological mechanisms remain incompletely understood despite extensive research.

    Purpose of the Study:

    • To outline the classification and pathophysiology of cardiorenal syndrome.
    • To highlight the diagnostic and therapeutic challenges in managing cardiorenal syndrome.
    • To emphasize the need for specific clinical guidelines for cardiorenal syndrome.

    Main Methods:

    • Review of existing literature on cardiorenal syndrome.
    • Classification of cardiorenal syndrome into five distinct types.
    • Discussion of pathophysiological mechanisms and clinical implications.

    Main Results:

    • Defined five types of cardiorenal syndrome: Type 1 (acute), Type 2 (chronic), Type 3 (acute renocardial), Type 4 (chronic renocardial), and Type 5 (secondary).
    • Highlighted the complexity and obscure nature of underlying pathophysiological disturbances.
    • Noted the lack of specific treatment guidelines for cardiorenal syndrome.

    Conclusions:

    • Cardiorenal syndrome necessitates prompt diagnosis and integrated management strategies.
    • Effective intervention requires addressing both cardiac and renal dysfunction.
    • Further research is needed to elucidate mechanisms and develop targeted therapies.